- Home
- A-Z Publications
- Current Cancer Therapy Reviews
- Previous Issues
- Volume 13, Issue 1, 2017
Current Cancer Therapy Reviews - Volume 13, Issue 1, 2017
Volume 13, Issue 1, 2017
-
-
Erlotinib: A Targeted Anticancer Drug
Authors: Parijat Pandey and Harish DurejaBackground: Over expression of epidermal growth factor receptor (EGFR) has been found to play a vital role in cancer of lung and pancreas. Therapies that target EGFR-mediated signalling are the latest keystone for treating these two types of cancer. Methodology: Erlotinib is an EGFR tyrosine kinase inhibitor, a promising anticancer agent either alone or as combination therapy for the treatment of both lung and pancr Read More
-
-
-
Cancer and Treatment Modalities
Authors: Elham Hosseinzadeh, Nooshin Banaee and Hassan Ali NedaieBackground: Cancer is one of the most dreadful diseases all over the world that can cause death. Cancer could be treated with different methods such as surgery, chemotherapy or radiotherapy. Methodology: In this review study, various techniques in cancer treatment especially radiotherapy modalities including three dimensional radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, intra o Read More
-
-
-
Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein
Background: Multi Drug Resistance (MDR) is one of the main hindrances in the successful treatment of cancer by natural agents. Most of the natural anticancer drugs are effluxed by the P-glycoprotein resulting in the failure of cancer chemotherapy. Phenothiazines and related drugs are one of the first drugs investigated for the reversal of MDR. Exhaustive studies have been done to develop potent phenothiazines analogu Read More
-
-
-
Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma
Authors: Ankita Maji, Sachin M and Dwaipayan SenBackground: Angiogenesis stands as a symbol for the development of tumor as well as its metastasis. In this review, we discuss the various components that induce and enhance angiogenesis along with its several inhibitors in neuroblastoma. Angiogenesis is vital for tumor development and migration and it is dependent on the creation of angiogenic elements by tumor cell lines. Methodology: Neuroblastoma (NB) is a gen Read More
-
-
-
Targeted Nanosystems for Cancer Therapy
Authors: Ruhee Jain, Tahseen Khan, Sourabh Jain, Ashutosh Pal Jain and Aakanchha JainBackground: Significant shortcomings have been displayed in conventional chemotherapeutics delivery which possesses some genuine side effects including harm of the immunity and different organs with quickly multiplying cells because of nonparticular focus on the absence of dissolvability and powerlessness to enter the tumor core bringing about debilitated treatment with diminished dosage and with low survival rate. Rapi Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/cctr
Journal
10
5
false
en
